NCT00710840

Brief Summary

Osteoarthritis (OA) is a long-term degenerative joint disease that disables about 10% of people over the age of 60 and compromises the quality of life of more than 20 million Americans. A procedure called total knee arthroplasty (TKA), in which the affected surface of the knee joint is replaced by plastic or metal, has been successful in restoring comfort and mobility to formerly arthritic joints. This study will compare quadriceps muscle strength, knee range of motion, and pain in people who have had a traditional TKA with those who have had a minimally invasive TKA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2008

Typical duration for phase_2

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

June 27, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 4, 2008

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

May 15, 2015

Completed
Last Updated

June 10, 2015

Status Verified

March 1, 2015

Enrollment Period

2.7 years

First QC Date

June 27, 2008

Results QC Date

March 18, 2015

Last Update Submit

May 14, 2015

Conditions

Keywords

Knee ReplacementKnee OAOA

Outcome Measures

Primary Outcomes (2)

  • Quadriceps Muscle Force

    Measured pre-operatively; post-surgery at 4 weeks and 12 weeks

  • Knee Range of Motion

    Knee Flexion Active Range of Motion (AROM)

    Measured pre-operatively; post-surgery at 4 weeks and 12 weeks

Secondary Outcomes (2)

  • Functional Performance: 6 Minute Walk (6MW) Distance

    Measured pre-operatively; post-surgery at 4 weeks and 12 weeks

  • Functional Performance: Stair Climb Test

    Measured pre-operatively; post-surgery at 4 weeks and 12 weeks

Study Arms (2)

1

EXPERIMENTAL
Procedure: Minimally Invasive Total Knee Arthroplasty [TKA Min]

2

ACTIVE COMPARATOR
Procedure: Total Knee Arthroplasty (TKA) Traditional

Interventions

TKA Min is a procedure in which diseased and painful joint surfaces of the knee are replaced by metal and plastic components shaped to allow continued motion of the knee. TKA Min, as opposed to TKA Traditional, employs smaller skin incisions and smaller instrumentation and avoids turning the knee cap out and dislocating the knee. This procedure also avoids disrupting the knee extensor mechanism and the suprapatellar pouch and minimizes extreme knee flexion during surgery.

Also known as: TKA Min
1

TKA is a procedure in which diseased and painful joint surfaces of the knee are replaced by metal and plastic components shaped to allow continued motion of the knee.

Also known as: TKA Traditional
2

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of osteoarthritis
  • Eligible for a unilateral or bilateral primary TKA to be performed by Dr. Michael Dayton (University of Colorado Hospital)
  • Minimum of 110 degrees of active knee flexion
  • No greater than 10 degrees of anatomic knee varus, 15 degrees anatomic valgus, and 10 degrees flexion contracture
  • Body mass index less ≤ 40 kg/m2

You may not qualify if:

  • Any brain, circulation, or heart problems that limit function
  • Severe osteoarthritis or other orthopedic conditions that limit function in the lower extremity that is not undergoing the TKA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Colorado Health Sciences Center

Boulder, Colorado, 80304, United States

Location

National Jewish Medical and Research Center

Denver, Colorado, 80206, United States

Location

University of Colorado Health Sciences Center

Denver, Colorado, 80262, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Limitations and Caveats

Small sample size; Relatively short follow-up time

Results Point of Contact

Title
Dr. Jennifer Stevens-Lapsley
Organization
University of Colorado Denver, Anschutz Medical Center

Study Officials

  • Jennifer E. Stevens, MPT, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR
  • Michael Dayton, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR
  • Wendy Kohrt, PhD

    University of Colorado School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2008

First Posted

July 4, 2008

Study Start

June 1, 2008

Primary Completion

February 1, 2011

Study Completion

January 1, 2012

Last Updated

June 10, 2015

Results First Posted

May 15, 2015

Record last verified: 2015-03

Locations